Ling Zhang
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 34
- MicroRNA in disease regulation 21
- Cancer, Hypoxia, and Metabolism 9
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 9
- Immunology top 5%
- Immune Cell Function and Interaction 8
- Molecular Biology top 5%
- RNA modifications and cancer 21
- Circular RNAs in diseases 16
- RNA Research and Splicing 8
- Gastroenterology top 5%
- Co-authors
- Jianping XiongNicholas P. RestifoSid P. KerkarRichard A. MorganSteven A. RosenbergZhili ZhengJun DengZhiya Yu
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Anti-Cancer Drugs (3 papers)BMC Cancer (3 papers)Biochemical and Biophysical Research Communications (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Ling Zhang
100 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 122
- Cancer Research 1.1k
- Oncology 855
- Immunology 641
- Molecular Biology 1.6k
- Gastroenterology 74
Countries citing papers authored by Ling Zhang
This map shows the geographic impact of Ling Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Zhang more than expected).
Fields of papers citing papers by Ling Zhang
This network shows the impact of papers produced by Ling Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Zhang. The network helps show where Ling Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ling Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 0 | |
| 8 | 2021 | 27 | |
| 9 | 2020 | 43 | |
| 10 | 2019 | 14 | |
| 11 | 2015 | 332 | |
| 12 | 2014 | 31 | |
| 13 | 2013 | 10 | |
| 14 | Operation of medial temporal lobe epilepsy with hippocampus lesion | 2012 | 1 |
| 15 | 2011 | 219 | |
| 16 | Aidi Injection Combined with Chemotherapy in Advanced Gastric Cancer | 2009 | 2 |
| 17 | 2008 | 2 | |
| 18 | 2007 | 21 | |
| 19 | Significance of the imbalance of Th1/Th2 function after acute myocardial infarction | 2005 | 2 |
| 20 | Nonradioactive iodide effectively induces apoptosis in genetically modified lung cancer cells. | 2003 | 36 |
About Ling Zhang
Ling Zhang is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 107 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (34 papers), RNA modifications and cancer (21 papers), MicroRNA in disease regulation (21 papers), Circular RNAs in diseases (16 papers), Colorectal Cancer Treatments and Studies (9 papers), Cancer, Hypoxia, and Metabolism (9 papers), Immune Cell Function and Interaction (8 papers) and RNA Research and Splicing (8 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (855 citations) and Immunology (641 citations). Ling Zhang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jianping Xiong, Nicholas P. Restifo, Sid P. Kerkar, Richard A. Morgan, Steven A. Rosenberg, Zhili Zheng, Jun Deng, Zhiya Yu, Junhe Li and Xiaojun Xiang. Their work appears in journals such as Anti-Cancer Drugs, BMC Cancer, Biochemical and Biophysical Research Communications, Frontiers in Oncology and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.